Welcome to LookChem.com Sign In|Join Free

CAS

  • or

23610-05-1

Post Buying Request

23610-05-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23610-05-1 Usage

Description

4-[(Z)-Amino(hydroxyimino)methyl]benzoic acid, commonly referred to as Z-AHMB, is a member of the benzoic acid class of chemical compounds. It is characterized by the presence of an amino group, a hydroxyimino group, and a carboxylic acid group, all of which are attached to a benzene ring. Z-AHMB's unique structure endows it with potential pharmaceutical applications, particularly as an antioxidant and anti-inflammatory agent. Its therapeutic potential is currently being explored for the treatment of a range of diseases and conditions, including cancer, inflammation, and oxidative stress, positioning it as a promising candidate for future medical interventions.

Uses

Used in Pharmaceutical Industry:
Z-AHMB is utilized as an antioxidant and anti-inflammatory agent for its potential to mitigate oxidative stress and inflammation, which are common pathological factors in various diseases.
Used in Cancer Treatment:
In the field of oncology, Z-AHMB is employed as a therapeutic agent for its potential to target cancer cells and inhibit their growth, making it a candidate for the treatment of various types of cancer.
Used in Inflammation Management:
Z-AHMB is used as an anti-inflammatory compound to manage conditions characterized by excessive inflammation, which can contribute to tissue damage and chronic diseases.
Used in Oxidative Stress Reduction:
As an antioxidant, Z-AHMB is applied to reduce oxidative stress, a condition implicated in the pathogenesis of numerous diseases and the aging process.
These applications highlight the versatility of Z-AHMB and its potential to contribute to the development of new therapeutic strategies across different areas of medicine.

Check Digit Verification of cas no

The CAS Registry Mumber 23610-05-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,6,1 and 0 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 23610-05:
(7*2)+(6*3)+(5*6)+(4*1)+(3*0)+(2*0)+(1*5)=71
71 % 10 = 1
So 23610-05-1 is a valid CAS Registry Number.

23610-05-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(N-hydroxycarbamimidoyl)-benzoic acid

1.2 Other means of identification

Product number -
Other names Benzenylamidoxim-p-carbonsaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23610-05-1 SDS

23610-05-1Relevant articles and documents

Synthesis, Antifungal Activity, DFT Study and Molecular Dynamics Simulation of Novel 4-(1,2,4-Oxadiazol-3-yl)-N-(4-phenoxyphenyl)benzamide Derivatives

Yang, Zihui,Liu, Qingsong,Sun, Yue,Sun, Xuebao,Chen, Linlin,Sun, Lu,Gu, Wen

, (2021/11/10)

In order to find novel potential antifungal agrochemicals, a series of new 4-(1,2,4-oxadiazol-3-yl)-N-(4-phenoxyphenyl)benzamide derivatives 3a–j were designed, synthesized and characterized by their 1H-, 13C-NMR and HRMS spectra. Th

Development of Potent 3-Br-isoxazoline-Based Antimalarial and Antileishmanial Compounds

Basilico, Nicoletta,Conti, Paola,Coser, Consuelo,Galbiati, Andrea,Parapini, Silvia,Tamborini, Lucia,Taramelli, Donatella,Zana, Aureliano

supporting information, p. 1726 - 1732 (2021/11/01)

Starting from the structure of previously reported 3-Br-isoxazoline-based covalent inhibitors of P. falciparum glyceraldehyde 3-phosphate dehydrogenase, and with the intent to improve their metabolic stability and antimalarial activity, we designed and synthesized a series of simplified analogues that are characterized by the insertion of the oxadiazole ring as a bioisosteric replacement for the metabolically labile ester/amide function. We then further replaced the oxadiazole ring with a series of five-membered heterocycles and finally combined the most promising structural features. All the new derivatives were tested in vitro for antimalarial as well as antileishmanial activity. We identified two very promising new lead compounds, endowed with submicromolar antileishmanial activity and nanomolar antiplasmodial activity, respectively, and a very high selectivity index with respect to mammalian cells.

SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI

-

Paragraph 68, (2019/03/14)

The present invention relates to trifluoromethyloxadiazoles of the formula I, or the N-oxides, or the agriculturally useful salts thereof, and the use thereof for controlling phytopathogenic fungi; to a method for combating phytopathogenic harmful fungi,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 23610-05-1